203 related articles for article (PubMed ID: 23799068)
1. A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.
Perez-Aguilar JM; Xi J; Matsunaga F; Cui X; Selling B; Saven JG; Liu R
PLoS One; 2013; 8(6):e66009. PubMed ID: 23799068
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information.
Zhao X; Perez-Aguilar JM; Matsunaga F; Lerner M; Xi J; Selling B; Johnson AT; Saven JG; Liu R
Anesthesiology; 2014 Oct; 121(4):866-75. PubMed ID: 24835677
[TBL] [Abstract][Full Text] [Related]
3. Novel variants of engineered water soluble mu opioid receptors with extensive mutations and removal of cysteines.
Xi J; Yang N; Perez-Aguilar JM; Selling B; Grothusen JR; Lamichhane R; Saven JG; Liu R
Proteins; 2021 Oct; 89(10):1386-1393. PubMed ID: 34152652
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an engineered water-soluble variant of the full-length human mu opioid receptor.
Xi J; Xiao J; Perez-Aguilar JM; Ping J; Johnson ATC; Saven JG; Liu R
J Biomol Struct Dyn; 2020 Sep; 38(14):4364-4370. PubMed ID: 31588852
[TBL] [Abstract][Full Text] [Related]
5. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
[TBL] [Abstract][Full Text] [Related]
6. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
[TBL] [Abstract][Full Text] [Related]
7. Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors.
Strahs D; Weinstein H
Protein Eng; 1997 Sep; 10(9):1019-38. PubMed ID: 9464566
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Xu W; Li J; Chen C; Huang P; Weinstein H; Javitch JA; Shi L; de Riel JK; Liu-Chen LY
Biochemistry; 2001 Jul; 40(27):8018-29. PubMed ID: 11434771
[TBL] [Abstract][Full Text] [Related]
9. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
Filizola M; Laakkonen L; Loew GH
Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
[TBL] [Abstract][Full Text] [Related]
10. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.
Rosa M; Bech-Serra JJ; Canals F; Zajac JM; Talmont F; Arsequell G; Valencia G
J Proteome Res; 2015 Aug; 14(8):3162-73. PubMed ID: 26090583
[TBL] [Abstract][Full Text] [Related]
11. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
12. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
13. Effective application of bicelles for conformational analysis of G protein-coupled receptors by hydrogen/deuterium exchange mass spectrometry.
Duc NM; Du Y; Zhang C; Lee SY; Thorsen TS; Kobilka BK; Chung KY
J Am Soc Mass Spectrom; 2015 May; 26(5):808-817. PubMed ID: 25740347
[TBL] [Abstract][Full Text] [Related]
14. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
Bera I; Laskar A; Ghoshal N
J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
[TBL] [Abstract][Full Text] [Related]
15. Engineering and functional immobilization of opioid receptors.
Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
[TBL] [Abstract][Full Text] [Related]
16. Computational design of a water-soluble analog of phospholamban.
Slovic AM; Summa CM; Lear JD; DeGrado WF
Protein Sci; 2003 Feb; 12(2):337-48. PubMed ID: 12538897
[TBL] [Abstract][Full Text] [Related]
17. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
Huang P; Li J; Chen C; Visiers I; Weinstein H; Liu-Chen LY
Biochemistry; 2001 Nov; 40(45):13501-9. PubMed ID: 11695897
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
19. Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.
Cvicek V; Goddard WA; Abrol R
PLoS Comput Biol; 2016 Mar; 12(3):e1004805. PubMed ID: 27028541
[TBL] [Abstract][Full Text] [Related]
20. Scalable production of highly sensitive nanosensors based on graphene functionalized with a designed G protein-coupled receptor.
Lerner MB; Matsunaga F; Han GH; Hong SJ; Xi J; Crook A; Perez-Aguilar JM; Park YW; Saven JG; Liu R; Johnson AT
Nano Lett; 2014 May; 14(5):2709-14. PubMed ID: 24742304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]